SmartGene services to be used for the local detection of SARS-CoV-2 variants and national surveillance across France.
SmartGene's Bacteria Module is the perfect complement to the Applied Biosystems SeqStudio™ Genetic Analyzer.
Genetic analyses of SARS-CoV-2 and other Coronaviridae will have an increasingly important role to play, both in the current fight against COVID-19 and in preventing future epidemics of Coronaviridae.
The reference sequences available in SmartGene's Influenza module have been updated.
SmartGene announces a clinical research collaboration with France's Centre of Excellence for the study and treatment of hepatitis viruses at the Virology Laboratory and National Reference Center for Viral Hepatitis B, C, and delta at Hospital Henri Mondor, University Paris-Est, Paris, France.
The IDNS Fungi 25-28S Reference Database has been reconfigured to improve coverage and species representation.
SmartGene receives certification of compatibility regarding the requirements of Title 21 Part 11 of the US Code of Federal Regulations.
Professor Anne-Geneviève Marcelin of Pitié-Salpêtrière Hospital Sorbonne, Paris, France presented the findings of a study based on data collected and analyzed using tools and search algorithms which SmartGene has made available for this purpose: Epidemiological study of Doravirine associated resistance mutations in HIV-1-infected treatment-naïve patients from two large databases in France and Italy.
With the release of version 5.3, SmartGene has applications available for HIV, Microbiome 16S, and HCV.